Benzodiazepine derivative for the treatment of hematopoietic neoplasm and leukemia

Details for Australian Patent Application No. 2010236747 (hide)

Owner Eli Lilly and Company

Inventors Chedid, Marcio

Agent Spruson & Ferguson

Pub. Number AU-A-2010236747

PCT Pub. Number WO2010/120614

Priority 61/169,094 14.04.09 US

Filing date 8 April 2010

Wipo publication date 21 October 2010

International Classifications

A61K 31/5517 (2006.01)

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

6 October 2011 PCT application entered the National Phase

  PCT publication WO2010/120614 Priority application(s): WO2010/120614

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010236758-Therapy management development platform

2010236743-System and method for local handset check of the NXX local exchange to determine carrier